0001603018-16-000002.txt : 20160224 0001603018-16-000002.hdr.sgml : 20160224 20160224163416 ACCESSION NUMBER: 0001603018-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160224 DATE AS OF CHANGE: 20160224 EFFECTIVENESS DATE: 20160224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alexza Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001344413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770567768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-258073 FILM NUMBER: 161452461 BUSINESS ADDRESS: STREET 1: 2091 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650.944.7000 MAIL ADDRESS: STREET 1: 2091 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 D 1 primary_doc.xml X0707 D LIVE 0001344413 Alexza Pharmaceuticals Inc. 2091 STIERLIN COURT MOUNTAIN VIEW CA CALIFORNIA 94043 650.944.7000 DELAWARE None None Corporation true Thomas B King 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Executive Officer Director Edwin S Kamemoto 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Executive Officer J Kevin Buchi 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Deepika R Pakianathan 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director J Leighton Read 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Gordon Ringold 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Isaac Stein 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Joseph L Turner 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Pharmaceuticals Decline to Disclose 06b false 2016-02-23 false true false 0 5000000 5000000 0 Shares issued in consideration of reduction in outstanding balance of a note dated 5/07/13 by $5,000,000 and forgiveness of accrued and unpaid interest thereunder as reported by the Issuer in its Current Report on Form 8-K filed with the SEC on 2/24/2016 false 1 0 0 0 true false Alexza Pharmaceuticals Inc. /s/ Thomas B. King Thomas B. King Pres & CEO 2016-02-24